There is a lack of diverse principal investigators leading medical device clinical studies, which impedes the inclusion of representative patient populations from the communities they are trying to serve. This lack of representation hinders the development of scientific evidence to support the effectiveness and safety of these technologies and therapeutics in minority patient populations
In today’s America, Black, Indigenous, (and) People Of Color (BIPOC) continue to have markedly worse health outcomes than white patients. The differences are greatest for Black Americans. Compared to White patients, they are two to three times as likely to die of preventable heart disease and stroke. They also have higher rates of cancer, asthma, influenza, pneumonia, diabetes, HIV/AIDS, and homicide. For many of them, structural racism and unequal treatment remain a contributing factor to disease and death.
In order to affect change and improve long term health outcomes in Black and Brown Americans, significant improvements in patient-provider racial and ethnic concordance is needed. Across the U.S., white doctors make up 56% of the physician workforce, with Asian doctors at 17%. Just under 6% are Hispanic doctors. Only 5% are black doctors.*
This is why it is critical that those that lead clinical trials, especially medical device trials, should be a part of our community; live where we live, understand how we live, and share our backgrounds. This reference tool helps identify diverse principal investigators and provides support for those investigators.
Purpose and Intended Use
To increase the visibility of BIPOC Physicians & Advanced Practice Providers to improve patient to provider racial and ethnic concordance, increase the awareness and inclusion of BIPOC Physicians & Practice Providers in clinical research, and to improve health outcomes in diverse racial and ethnic patient populations.
Existing Diverse Principal Investigator Databases
National Medical Association Project I.M.P.A.C.T 2.0
The National Medical Association (NMA) is launching the formation of the Project IMPACT 2.0 (Increase Minority Participation and Awareness of Clinical Trials) Coalition. Since its inception in 1999, Project IMPACT has remained steadfast in its commitment to improve the validity of clinical trials data in African American and other minority patients. The Project IMPACT 2.0 Coalition will bring together stakeholders from industry, research institutions, regulatory agencies and the community to examine critical barriers to diverse participation in clinical research, to educate providers and consumers about the importance of diversity in clinical research, and to identify opportunities for underrepresented minority providers to participate as investigators in clinical research, all in an effort to increase our impact.
Principal Investigator Training Resources
Health Equity Resources
*Disclaimer: You are leaving MTC’s website. MTC cannot guarantee the accuracy or completeness of information contained on a linked website. MTC does not endorse linked websites or the views they express.*